首頁 > 市場調查報告書 > 製藥

眼科藥物

市場調查報告書

商品編碼

1477244

全球妥布黴素眼藥水市場，依類型、適應症、配銷通路和地理位置

Global Tobramycin Eye Drop Market, By Type, By Indication, By Distribution Channel, and Geography

出版日期: 2024年04月24日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球妥布黴素眼藥水市值為10.189億美元，預計2031年將達到25.732億美元，2024年至2031年的年複合成長率（CAGR）為14.1%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	10.189 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	14.10%	2031 年價值預測：	25.732 億美元

數字。 2024 年全球妥布黴素眼藥水市場佔有率 (%)，依地區分類

妥布黴素眼藥水是外用氨基糖苷類抗生素，用於治療敏感革蘭氏陰性菌引起的外眼感染。這些藥物透過干擾細菌蛋白質合成來發揮作用，從而阻止有害細菌的生長。由於長時間使用電腦、配戴隱形眼鏡、眼科手術等危險因子的增加，全球眼部感染的盛行率不斷上升，增加了對妥布黴素眼藥水的需求。

市場動態：

由於眼部疾病盛行率上升、更容易出現眼部問題的老年人口增加以及人們對眼睛護理意識的提高等因素，全球妥布黴素眼藥水市場一直在成長。然而，由於長期使用妥布黴素眼藥水帶來的副作用（如眼睛刺激、結膜炎等）等因素，市場成長可能會受到阻礙。使用妥布黴素的新型藥物輸送方法和聯合療法的持續研究和開發為市場參與者提供了利潤豐厚的機會。

研究的主要特點：

該報告對全球妥布黴素眼藥水市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模（百萬美元）和年複合成長率（CAGR% ）。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數介紹了全球妥布黴素眼藥水市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球妥布黴素眼藥水市場迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球妥布黴素眼藥水市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 9 章：競爭格局

公司簡介
- AdvaCare Pharma
- Beye, LLC.
- Grevis Pharmaceuticals Pvt Ltd.
- Elvia Care Pvt Ltd
- Novalab Healthcare
- Zydus Group
- Bausch + Lomb
- Hilbert Healthcare
- Sanify Healthcare
- Choroid Laboratories Private Limited.
- Torainse Lifecare Pvt. Ltd.
- Divine Laboratories Private Limited
- Incepta Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Limited

第 10 章：分析師建議

命運之輪
分析師觀點
連貫的機會圖

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6923

Global tobramycin eye drop market is estimated to be valued at USD 1,018.9 Mn in 2024 and is expected to reach USD 2,573.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1,018.9 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	14.10%	2031 Value Projection:	US$ 2,573.2 Mn

Figure. Global Tobramycin Eye Drop Market Share (%), By Region 2024

Global Tobramycin Eye Drop Market - IMG1

Tobramycin eye drops are topical aminoglycoside antibiotics that are used for treating external eye infections caused by susceptible Gram-negative bacteria. These work by interfering with bacterial protein synthesis, thus, stopping the growth of harmful bacteria. The expanding prevalence of ocular infections globally due to increasing risk factors such as prolonged computer use, contact lens wear, eye surgeries, and others boosts demand for tobramycin eye drops

Market Dynamics:

Global tobramycin eye drop market has been witnessing growth due to factors such as rising prevalence of eye diseases, growing elderly population who are more prone to eye problems, increasing awareness about eye care. However, the market growth can be hindered due to factors such as side effects associated with long-term use of tobramycin eye drops like eye irritation, conjunctivitis, and others. Ongoing research and development for novel drug delivery methods and combination therapies using tobramycin offers lucrative opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global tobramycin eye drop market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global tobramycin eye drop market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study AdvaCare Pharma, Beye, LLC., Grevis Pharmaceuticals Pvt Ltd., Elvia Care Pvt Ltd, Novalab Healthcare, Zydus Group, Bausch + Lomb, Hilbert Healthcare, Sanify Healthcare, Choroid Laboratories Private Limited., Torainse Lifecare Pvt. Ltd., Divine Laboratories Private Limited, Incepta Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global tobramycin eye drop market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tobramycin eye drop market.

Detailed Segmentation-

By Type:
- Tobramycin and Dexamethasone Suspension
- Tobramycin Suspension
- Others Tobramycin Combinations
By Indication:
- Bacterial Eye Infections
- Keratitis
- Pre-/post-ocular Surgery Prophylaxis
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AdvaCare Pharma
- Beye, LLC.
- Grevis Pharmaceuticals Pvt Ltd.
- Elvia Care Pvt Ltd
- Novalab Healthcare
- Zydus Group
- Bausch + Lomb
- Hilbert Healthcare
- Sanify Healthcare
- Choroid Laboratories Private Limited.
- Torainse Lifecare Pvt. Ltd.
- Divine Laboratories Private Limited
- Incepta Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Tobramycin Eye Drop Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Tobramycin Eye Drop Market, By Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Tobramycin and Dexamethasone Suspension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Tobramycin Suspension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others Tobramycin Combinations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Tobramycin Eye Drop Market, By Indication, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Bacterial Eye Infections
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Keratitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Pre-/post-ocular Surgery Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Tobramycin Eye Drop Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Tobramycin Eye Drop Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
North Africa
Central Africa
South Africa